Key statistics dashboard for Eli Lilly and Company (LLY). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
Eli Lilly and Company is a prominent global pharmaceutical firm dedicated to the research, development, and commercialization of human medicines across the world. Its therapeutic offerings include a comprehensive suite of diabetes medications. This encompasses various insulin formulations like Basaglar, the Humalog family (e.g., Mix 75/25, U-100, U-200, Mix 50/50), insulin lispro products (including protamine and mix 75/25), and the Humulin line (e.g., 70/30, N, R, U-500).
Stock Data
| Price | $1,143.12 |
| Market Cap | $1.1T |
| Enterprise Value | $1.12T |
| Beta | 0.50 |
| Exchange | NYSE |
| Country | US |
Valuation Multiples
| P/E Ratio | 38.24 |
| Price / Book | 30.11 |
| P/S | 13.51 |
| EV/EBITDA | 25.92 |
| EV/Sales | 14.09 |
| EV/FCF | 55.98 |
| P/FCF | 53.68 |
| Earnings Yield | 2.62% |
| FCF Yield | 1.86% |
| Dividend Yield | 0.59% |
Profitability
| Gross Margin | 83.40% |
| EBIT Margin | 51.72% |
| EBITDA Margin | 54.36% |
| Operating Margin | 49.72% |
| Net Margin | 33.53% |
| Return on Equity | 92.58% |
| Return on Assets | 18.77% |
| Return on Invested Capital | 31.00% |
| Return on Capital Employed | 41.90% |
Financial Health
| Current Ratio | 1.35 |
| Quick Ratio | 1.00 |
| Cash Ratio | 0.19 |
| Debt / Equity | 1.62 |
| Debt / Assets | 38.59% |
| Net Debt / EBITDA | 1.06 |
| Interest Coverage | 40.43 |
| Piotroski F-Score | 7 |
| Altman Z-Score | 8.71 |
Per-Share Data
| Revenue per share | 89.27 |
| Book Value per share | 37.96 |
| Cash per share | 10.03 |
| FCF per share | 22.47 |
| Tangible Book Value per share | 7.75 |
| Dividend per share | 6.69 |
Analyst Consensus
| Strong Buy | 0 |
| Buy | 33 |
| Hold | 9 |
| Sell | 3 |
| Strong Sell | 0 |
| Total analysts | 45 |
| Avg rating (1-5) | 0.67 |
Related companies: ABBV · AMGN · AZN · GILD · JNJ · MRK · NVO
Explore sector: Healthcare · Drug Manufacturers - General
More sections of LLY: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks